NASDAQ:AYLA

Ayala Pharmaceuticals, Inc Earning Date

USA |NASDAQ |USD

AYLA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 15, 2021 Sep 2021 $-0.80 $-0.75 $-0.59
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 15, 2021 Sep 2021 $840.00K $761.00K $658.00K

Ayala Pharmaceuticals, Inc's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 2021.

AYLA Earnings Date & History Chart

AYLA Earnings & Revenue Forecast

AYLA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.74 $-0.97 $-0.59
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-2.96 $-3.50 $-2.63
Dec 2022 6 $-2.77 $-3.93 $-0.69

AYLA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.74 $-0.61 $-0.61
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.96 $-2.66 $-2.57
Dec 2022 0 / 0 $-2.77 $-2.33 $-2.71

AYLA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $960.00K $760.00K $1.10M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $3.57M $3.26M $3.90M
Dec 2022 5 $3.65M $3.26M $4.00M

AYLA Earnings Date & Revenue History

AYLA Earnings History

|
Show More
Show More

AYLA Revenue History

|
Show More
Show More

Ayala Pharmaceuticals, Inc Next Earnings Date & Report

AYLA Next Earnings Date & Report Preview: Sep 2021 (FQ)

AYLA's next earnings date is Monday, Nov 15, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Ayala Pharmaceuticals, Inc's next quarterly earnings is $-0.80, with a low EPS estimation of $-0.93, and a high estimation of $-0.70.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.80, the last 2 month trend is $-0.67, and the 3 month trend is $-0.63.

Based on 3 analysts, the average revenue estimation is $840.00K, with a low revenue estimation of $700.00K, and a high estimation of $1.00M.

Ayala Pharmaceuticals, Inc Previous Earnings Dates & Reports

AYLA Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Ayala Pharmaceuticals, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

AYLA's earnings per share (EPS) was $-0.75, missing the consensus analysts forecast of $-0.62 by -20.97%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 1.35%, and lower than the same period a year before (Jun 2020) by 1.35%.

Revenues were $761.00K, worse than the forecast of $1.02M by -25.39%, down by -21.87% from the previous quarter , and down by -27.18% from the same period last year.

The company reported a net income of $-10.84M.

Free cash flow for the quarter was $-11.55M , compared to $-9.65M last quarter and $-5.33M a year before.

AYLA ended the quarter with $502.00K in total debt, a decrease of -0.59% compared to the previous quarter, and a decrease of -8.39% compared to the same quarter a year before.

AYLA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Ayala Pharmaceuticals, Inc's previous annual earnings date was Mar 24, 2021 for its fiscal year ended Dec 31, 2020.

AYLA's earnings per share (EPS) was $-3.38.

Revenues were $3.71M, better than the forecast of $3.71M by 0.00%, and up by 58.87% from previous year's revenue.

The company reported a net income of $-30.15M.

Ayala Pharmaceuticals, Inc reported a free cash flow of $-27.59M for its fiscal year, compared to $-16.28M a year ago.

The company ended the fiscal year with $553.00K in total debt, an increase of 84.95% compared to the previous year.